Carolyn Hugley

Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
  • S&P Global reports strong Q3 results, raises full-year guidance, and plans strategic divestitures amid market volatility.
  • College football's coaching carousel sees major vacancies amid political and diversity challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
  • S&P Global reports strong Q3 results, raises full-year guidance, and plans strategic divestitures amid market volatility.
  • College football's coaching carousel sees major vacancies amid political and diversity challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Carolyn Hugley